A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 33,699 shares of SWAV stock, worth $11.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
33,699
Previous 39,465 14.61%
Holding current value
$11.3 Million
Previous $7.52 Million 45.92%
% of portfolio
0.06%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$191.17 - $325.63 $1.1 Million - $1.88 Million
-5,766 Reduced 14.61%
33,699 $11 Million
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $654,102 - $876,348
-4,063 Reduced 9.33%
39,465 $7.52 Million
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $726,016 - $1.06 Million
3,736 Added 9.39%
43,528 $8.67 Million
Q2 2023

Aug 11, 2023

SELL
$223.05 - $302.68 $972,498 - $1.32 Million
-4,360 Reduced 9.87%
39,792 $11.4 Million
Q1 2023

May 12, 2023

BUY
$175.41 - $217.92 $321,877 - $399,883
1,835 Added 4.34%
44,152 $9.57 Million
Q4 2022

Feb 13, 2023

SELL
$204.38 - $296.82 $2.8 Million - $4.07 Million
-13,711 Reduced 24.47%
42,317 $8.7 Million
Q3 2022

Nov 10, 2022

BUY
$195.21 - $310.53 $509,302 - $810,172
2,609 Added 4.88%
56,028 $15.6 Million
Q2 2022

Aug 11, 2022

BUY
$115.91 - $214.48 $585,113 - $1.08 Million
5,048 Added 10.44%
53,419 $10.2 Million
Q1 2022

May 13, 2022

BUY
$127.96 - $207.36 $1.54 Million - $2.49 Million
12,024 Added 33.08%
48,371 $10 Million
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $697,839 - $1.02 Million
4,226 Added 13.16%
36,347 $6.48 Million
Q3 2021

Nov 12, 2021

SELL
$163.99 - $235.57 $448,020 - $643,577
-2,732 Reduced 7.84%
32,121 $6.61 Million
Q2 2021

Aug 13, 2021

BUY
$131.45 - $201.49 $4.58 Million - $7.02 Million
34,853 New
34,853 $6.61 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Market Cap $12B
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.